Company News

P&G Inks OTC Deal with Teva

Creates opportunities to move product from Rx-to-OTC.

Author Image

By: TOM BRANNA

Editor

The Procter & Gamble Company and Teva Pharmaceutical Industries Ltd. will create a partnership in consumer health care by bringing together both companies’ existing over-the-counter (OTC) medicines and complementary capabilities to accelerate growth. This new business model combines P&G’s brand-building, consumer-led innovation and go-to-market capabilities with Teva’s broad geographic reach, its experience in R&D, regulatory and manufacturing and its extensive portfolio of p...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters